Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Patients with primary hyperparathyroidism (pHPT) with osteopenia and osteoporosis are treated
with strontium ranelate/Ca+Vitamin-D or placebo/Ca+Vitamin D after successful surgical
treatment of pHPT.
Strontium ranelate/Ca + Vitamin-D helps to regain bone mass in patients with osteopenia or
osteoporosis after successful parathyroidectomy for pHPT and results in higher gain of BMD
than placebo treated patients.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Vienna
Collaborator:
National Bank of Austria
Treatments:
Ergocalciferols Strontium ranelate Vitamin D Vitamins